Evidence map›Paper›PMID 27408075›Full record

ArticleMedical journal, Armed Forces India2008

Detection of Bacterial Pathogens in Cerebrospinal Fluid using Restriction Fragment Length Polymorphism.

A T Kalghatgi, A K Praharaj, A K Sahni, D Pradhan, S Kumaravelu, P L Prasad, A Nagendra

Abstract read
In one paragraph

Article in Medical journal, Armed Forces India, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Review
  2. Article
  3. Molecular detection and PCR-RFLP analysis usingJournal, genetic engineering & biotechnology · 2018
    Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

A T KalghatgiSenior Advisor (Pathology), Command Hospital (Central Command), Lucknow.
A K PraharajPDMS (HS) DGMS Navy, Naval HQ, New Delhi.
A K SahniSenior Advisor (Pathology), AH(R&R), Delhi Cantt.
D PradhanPost Graduate Trainee (Department of Microbiology), AFMC Pune-40.
S KumaraveluComdt, 155 BH, C/o 99 APO.
P L PrasadSenior Advisor (Paediatrics), Command Hospital (Central Command), Lucknow.
A NagendraEx- Dy Comdt, Command Hospital (Western Command), Chandigarh.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundPolymerase chain reaction (PCR) is useful for rapid microbial detection in body fluids with low microbial load. It is easier to use universal or broad range primers for the amplification of conserved stretches of DNA common to all bacteria like 16S rRNA gene, followed by restriction fragment length polymorphism (RFLP) of PCR products.

methodsForty samples of cerebrospinal fluid were collected. After DNA extraction, universal or broad range PCR was performed using two universal primers U1-5'-CCAGCAGCCGCGGTAATACG-3', corresponding to nucleotides 518 to 537 of the Escherichia coli 16S rRNA gene, and U2 - 5'-ATCGG(C/T)TACCTTGTTACGACTTC-3', corresponding to nucleotides 1513 to 1491 of the same gene. The PCR product was subjected to digestion by endonucleases- HaeIII, Mn11, BstB1 and Alu1. Restriction pattern obtained was compared with that of standard organisms to identify the pathogen. The results were compared with conventional methods.

resultUniversal PCR could detect pathogens in 20% samples within 13-18 hours as compared to 16% by conventional methods. The analytical sensitivity was 10 Gram negative and 250 Gram positive organisms per 200 μl sample. Overall sensitivity was 83.3% and specificity was 91.2%.

conclusionUniversal PCR followed by RFLP of PCR product is a good alternative to conventional diagnosis of bacterial pathogens.

Indexed as

Body fluidsPolymerase chain reactionRestriction fragment length polymorphism

Identifiers

PMID27408075
PMCPMC4921753

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.